Apellis Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US03753U1060
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityAPLS / Apellis Pharmaceuticals, Inc.
InstitutionParallel Advisors, LLC
Latest Disclosed Ownership1,692 shares
Latest Disclosed Value $ 42,503
Parallel Advisors, LLC ownership in APLS / Apellis Pharmaceuticals, Inc.

On February 11, 2026 - Parallel Advisors, LLC filed a 13F-HR form disclosing ownership of 1,692 shares of Apellis Pharmaceuticals, Inc. (US:APLS) valued at $42,503 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 1,970 shares of Apellis Pharmaceuticals, Inc.. This represents a change in shares of -14.11% during the quarter. The current value of the position is $69,423 USD.

Parallel Advisors, LLC has a history of taking positions in derivatives of the underlying security (APLS) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

APLS / Apellis Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F APELLIS PHARMACEUTICALS INC COM Stock 03753U106 1,692 -278 -14.11 43 -4.55 0.0008
2025-11-13 2025-09-30 13F APELLIS PHARMACEUTICALS INC COM Stock 03753U106 1,970 46 2.39 45 33.33 0.0008
2025-07-08 2025-06-30 13F APELLIS PHARMACEUTICALS INC COM Stock 03753U106 1,924 855 79.98 33 43.48 0.0007
2025-04-08 2025-03-31 13F APELLIS PHARMACEUTICALS INC COM Stock 03753U106 1,069 332 45.05 23 0.00 0.0005
2025-02-10 2024-12-31 13F APELLIS PHARMACEUTICALS INC COM Stock 03753U106 737 -1,142 -60.78 24 -57.41 0.0005
2024-11-13 2024-09-30 13F APELLIS PHARMACEUTICALS INC COM Stock 03753U106 1,879 250 15.35 54 -12.90 0.0013
2024-08-08 2024-06-30 13F APELLIS PHARMACEUTICALS INC COM Stock 03753U106 1,629 88 5.71 62 -31.11 0.0016
2024-05-06 2024-03-31 13F APELLIS PHARMACEUTICALS INC COM Stock 03753U106 1,541 44 2.94 91 1.12 0.0025
2024-02-12 2023-12-31 13F APELLIS PHARMACEUTICALS INC COM Stock 03753U106 1,497 71 4.98 90 64.81 0.0027
2024-05-20 2023-09-30 13F/A-1 APELLIS PHARMACEUTICALS INC COM Stock 03753U106 1,426 470 49.16 54 -37.93 0.0018
2023-11-14 2023-09-30 13F APELLIS PHARMACEUTICALS INC COM Stock 03753U106 1,426 470 54 0.0018
2024-05-20 2023-06-30 13F/A-1 APELLIS PHARMACEUTICALS INC COM Stock 03753U106 956 14 1.49 87 40.32 0.0028
2023-08-04 2023-06-30 13F APELLIS PHARMACEUTICALS INC COM Stock 03753U106 956 14 87 0.0028
2024-05-20 2023-03-31 13F/A-1 APELLIS PHARMACEUTICALS INC COM Stock 03753U106 942 868 1,172.97 62 1,966.67 0.0021
2023-04-25 2023-03-31 13F APELLIS PHARMACEUTICALS INC COM Stock 03753U106 942 868 62 0.0021
2023-02-06 2022-12-31 13F APELLIS PHARMACEUTICALS INC COM Stock 03753U106 74 -7 -8.64 4 -50.00 0.0002
2022-11-10 2022-09-30 13F APELLIS PHARMACEUTICALS INC COM Stock 03753U106 81 7 9.46 6 100.00 0.0003
2022-08-01 2022-06-30 13F APELLIS PHARMACEUTICALS INC COM Stock 03753U106 74 -56 -43.08 3 -50.00 0.0001
2022-04-28 2022-03-31 13F APELLIS PHARMACEUTICALS INC COM Stock 03753U106 130 -2 -1.52 6 0.00 0.0002
2022-01-20 2021-12-31 13F APELLIS PHARMACEUTICALS INC COM Stock 03753U106 132 73 123.73 6 200.00 0.0002
2021-11-02 2021-09-30 13F/A-1 APELLIS PHARMACEUTICALS INC COM Stock 03753U106 59 0 0.00 2 -50.00 0.0001
2021-08-06 2021-06-30 13F APELLIS PHARMACEUTICALS INC COM Stock 03753U106 59 0 0.00 4 33.33 0.0002
2021-04-23 2021-03-31 13F APELLIS PHARMACEUTICALS INC COM Stock 03753U106 59 0 0.00 3 0.00 0.0001
2021-02-02 2020-12-31 13F APELLIS PHARMACEUTICALS INC COM Stock 03753U106 59 -51 -46.36 3 0.00 0.0002
2020-10-27 2020-09-30 13F APELLIS PHARMACEUTICALS INC COM Stock 03753U106 110 -45 -29.03 3 -40.00 0.0002
2020-07-16 2020-06-30 13F APELLIS PHARMACEUTICALS INC COM Stock 03753U106 155 155 5 0.0003
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-01-19 2021-12-31 13F APELLIS PHARMACEUTICALS INC COM Stock Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-10-22 2021-09-30 13F APELLIS PHARMACEUTICALS INC COM Stock Call 59 4 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.